Dura Pharmaceuticals
AcquiredSan Diego, United States · Founded 1989
- Headquarters
- San Diego, California
- Founded
- 1989
- Business Model
- B2B
About
Dura Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on the development and marketing of prescription drugs, including synthetic peptides for the treatment of allergies and asthma. The company was acquired by Elan Corporation in November 2000 for approximately $1.8 billion in a stock swap transaction.
Summary
Dura Pharmaceuticals is a peptides company based in San Diego, United States, founded in 1989.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2000
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
BridgeBio makes targeted treatments for genetic diseases.
Novel bicyclic peptides and drug conjugates for cancer
R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.
Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases
Innovation-driven biopharmaceutical company developing and commercializing oncology and autoimmun...
Biopharmaceutical company developing and commercializing therapeutic products for prevention and ...